highly significantp < 0.0001
The difference in MDA levels between the healthy and erlotinib groups was highly significant ( p < 0.0001).
The difference in MDA levels between the healthy and erlotinib groups was highly significant ( p < 0.0001).
Although primordial follicle and corpus luteum numbers showed partial improvement in treatment groups, these differences did not reach statistical significance ( Figure 3 ). 4.